Literature DB >> 20414250

A two-stage case-control association study of the dihydropyrimidinase-like 2 gene (DPYSL2) with schizophrenia in Japanese subjects.

Takayoshi Koide1, Branko Aleksic, Yoshihito Ito, Hinako Usui, Akira Yoshimi, Toshiya Inada, Michio Suzuki, Ryota Hashimoto, Masatoshi Takeda, Nakao Iwata, Norio Ozaki.   

Abstract

We examined the association of schizophrenia (SCZ) and dihydropyrimidinase-like 2 (DPYSL2), also known as collapsin response mediator protein 2, which regulates axonal growth and branching. We genotyped 20 tag single nucleotide polymorphisms (SNPs) in 1464 patients and 1310 controls. There were two potential associations in a screening population of 384 patients and 384 controls (rs2585458: P=0.046, rs4733048: P=0.014). However, we could not replicate these associations in a confirmatory population of 1080 patients and 926 controls (rs2585458: P=0.39, rs4733048: P=0.70) or a joint analysis (rs2585458: P=0.72, rs4733048: P=0.10). We conclude that DPYSL2 does not have a major function in SCZ in Japanese subjects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20414250     DOI: 10.1038/jhg.2010.38

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  9 in total

1.  The suppression of CRMP2 expression by bone morphogenetic protein (BMP)-SMAD gradient signaling controls multiple stages of neuronal development.

Authors:  Yiming Sun; Teng Fei; Tao Yang; Feng Zhang; Ye-Guang Chen; Huashun Li; Zhiheng Xu
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

Review 2.  Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications.

Authors:  Kenneth Hensley; Kalina Venkova; Alexandar Christov; William Gunning; Joshua Park
Journal:  Mol Neurobiol       Date:  2011-01-28       Impact factor: 5.590

Review 3.  CRMPs: critical molecules for neurite morphogenesis and neuropsychiatric diseases.

Authors:  T T Quach; J Honnorat; P E Kolattukudy; R Khanna; A M Duchemin
Journal:  Mol Psychiatry       Date:  2015-06-16       Impact factor: 15.992

Review 4.  Psychiatric disorders biochemical pathways unraveled by human brain proteomics.

Authors:  Verônica M Saia-Cereda; Juliana S Cassoli; Daniel Martins-de-Souza; Juliana M Nascimento
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-07-04       Impact factor: 5.270

5.  Association between DPYSL2 gene polymorphisms and alcohol dependence in Caucasian samples.

Authors:  Amanda Taylor; Ke-Sheng Wang
Journal:  J Neural Transm (Vienna)       Date:  2013-07-12       Impact factor: 3.575

6.  Kaempferia parviflora rhizome extract and Myristica fragrans volatile oil increase the levels of monoamine neurotransmitters and impact the proteomic profiles in the rat hippocampus: Mechanistic insights into their neuroprotective effects.

Authors:  Waluga Plaingam; Siriporn Sangsuthum; Wannee Angkhasirisap; Tewin Tencomnao
Journal:  J Tradit Complement Med       Date:  2017-06-15

7.  Wisconsin Card Sorting Test scores and clinical and sociodemographic correlates in Schizophrenia: multiple logistic regression analysis.

Authors:  Masahiro Banno; Takayoshi Koide; Branko Aleksic; Takashi Okada; Tsutomu Kikuchi; Kunihiro Kohmura; Yasunori Adachi; Naoko Kawano; Tetsuya Iidaka; Norio Ozaki
Journal:  BMJ Open       Date:  2012-11-06       Impact factor: 2.692

8.  Association study of BCL9 gene polymorphism rs583583 with schizophrenia and negative symptoms in Japanese population.

Authors:  Hiroki Kimura; Satoshi Tanaka; Itaru Kushima; Takayoshi Koide; Masahiro Banno; Tsutomu Kikuchi; Yukako Nakamura; Tomoko Shiino; Akira Yoshimi; Tomoko Oya-Ito; Jingrui Xing; Chenyao Wang; Yuto Takasaki; Branko Aleksic; Takashi Okada; Masashi Ikeda; Toshiya Inada; Tetsuya Iidaka; Nakao Iwata; Norio Ozaki
Journal:  Sci Rep       Date:  2015-10-23       Impact factor: 4.379

9.  Evidence for contribution of common genetic variants within chromosome 8p21.2-8p21.1 to restricted and repetitive behaviors in autism spectrum disorders.

Authors:  Yu Tao; Hui Gao; Benjamin Ackerman; Wei Guo; David Saffen; Yin Yao Shugart
Journal:  BMC Genomics       Date:  2016-03-01       Impact factor: 3.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.